SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Meditrust NYSE: MT -- Ignore unavailable to you. Want to Upgrade?

To: Wren who wrote (137)11/9/1999 12:08:00 PM
From: M. Frank Greiffenstein  Read Replies (1) | Respond to of 233
 
So what is your take, Wren?

You started this thread, so finish what you started <g>.

In re-reading the PR, it seems MT is trying to cut costs by eliminating layers of management, particularly in the LaQuinta unit. They have nice cash flow and can easily cover their maturing Y2000 debt.

I don't see much downside risk from here, the dividend reduction has been factored into the price (But I said that at 8,5 <g>).


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News